Your browser is no longer supported. Please, upgrade your browser.
TXMD TherapeuticsMD, Inc. daily Stock Chart
TXMD [NASD]
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own12.67% Shs Outstand271.46M Perf Week-5.04%
Market Cap292.26M Forward P/E- EPS next Y-0.31 Insider Trans-0.91% Shs Float236.17M Perf Month-35.80%
Income-193.50M PEG- EPS next Q-0.17 Inst Own68.30% Short Float34.47% Perf Quarter-33.14%
Sales58.00M P/S5.04 EPS this Y-21.30% Inst Trans-5.12% Short Ratio16.22 Perf Half Y-55.69%
Book/sh-0.17 P/B- EPS next Y63.10% ROA-75.10% Target Price- Perf Year-62.33%
Cash/sh0.66 P/C1.72 EPS next 5Y21.80% ROE- 52W Range0.85 - 4.32 Perf YTD-53.31%
Dividend- P/FCF- EPS past 5Y-14.60% ROI-79.10% 52W High-73.84% Beta2.21
Dividend %- Quick Ratio3.20 Sales past 5Y27.00% Gross Margin85.70% 52W Low32.47% ATR0.14
Employees348 Current Ratio3.40 Sales Q/Q215.40% Oper. Margin- RSI (14)46.51 Volatility8.00% 12.03%
OptionableYes Debt/Eq- EPS Q/Q-27.80% Profit Margin- Rel Volume0.75 Prev Close1.17
ShortableYes LT Debt/Eq- EarningsMay 06 BMO Payout- Avg Volume5.02M Price1.13
Recom1.90 SMA20-10.23% SMA501.15% SMA200-50.95% Volume3,770,826 Change-3.42%
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Nov-01-13Initiated Stifel Buy $8
May-27-20 09:47AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
May-25-20 09:36PM  Edited Transcript of TXMD earnings conference call or presentation 6-May-20 12:30pm GMT Thomson Reuters StreetEvents
May-08-20 06:50AM  TherapeuticsMD Announces Participation at the BofA Securities 2020 Health Care Conference Business Wire
May-07-20 12:00AM  TherapeuticsMD Inc (TXMD) Q1 2020 Earnings Call Transcript Motley Fool
May-06-20 09:35AM  TherapeuticsMD (TXMD) Reports Q1 Loss, Tops Revenue Estimates Zacks -7.58%
07:15AM  TherapeuticsMD: Q1 Earnings Insights Benzinga
06:50AM  TherapeuticsMD Announces First Quarter 2020 Financial Results Business Wire
Apr-29-20 03:00PM  Here's Why TherapeuticsMD Stock Is Rocketing Higher Today Motley Fool +78.01%
12:34PM  Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out for Zacks
06:50AM  TherapeuticsMD Announces Issuance of First Orange Book Listable U.S. Patent for ANNOVERA® Business Wire
Apr-28-20 06:50AM  TherapeuticsMD to Report First Quarter 2020 Results on May 6, 2020 Business Wire
Apr-27-20 12:32PM  Earnings Preview: TherapeuticsMD (TXMD) Q1 Earnings Expected to Decline Zacks +5.89%
Apr-22-20 06:50AM  TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director Business Wire
Mar-27-20 08:02AM  The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance Benzinga -16.28%
Mar-26-20 04:05PM  TherapeuticsMD Provides COVID-19-Related Business Update Business Wire
Mar-24-20 07:45AM  TherapeuticsMD Strengthens Board with Appointment of Industry Leaders Business Wire +22.04%
Mar-16-20 06:00AM  TherapeuticsMD Provides Business Update on COVID-19 Pandemic Business Wire -15.44%
Mar-12-20 11:21AM  Is the Options Market Predicting a Spike in TherapeuticsMD (TXMD) Stock? Zacks -10.53%
Mar-11-20 06:25PM  Edited Transcript of TXMD earnings conference call or presentation 20-Feb-20 1:30pm GMT Thomson Reuters StreetEvents -5.59%
Mar-03-20 12:56PM  Analysts: These 3 Strong Buy Penny Stocks Could Gain Over 200% TipRanks
Feb-24-20 08:30AM  TherapeuticsMD, Inc. Yearly Results Just Came Out: Here's What Analysts Are Forecasting For Next Year Simply Wall St. -7.77%
Feb-20-20 08:15AM  TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates Zacks -10.42%
06:57AM  TherapeuticsMD Announces Fourth Quarter and Full-Year 2019 Financial Results Business Wire
06:30AM  TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-20 12:31PM  Earnings Preview: TherapeuticsMD (TXMD) Q4 Earnings Expected to Decline Zacks
06:30AM  TherapeuticsMD and Afaxys Enter Into Agreement to Expand Access to ANNOVERA® in the U.S. Public Health Sector Business Wire
Feb-10-20 06:30AM  TherapeuticsMD to Report Fourth Quarter 2019 Results on February 20, 2020 Business Wire
Feb-03-20 06:30AM  TherapeuticsMD Announces Submission of New Drug Application Prior Approval Efficacy Supplement to the U.S. Food and Drug Administration for Lower Dose of BIJUVA® Business Wire
Jan-15-20 10:37AM  How Much Are TherapeuticsMD, Inc. (NASDAQ:TXMD) Insiders Spending On Buying Shares? Simply Wall St.
Jan-07-20 06:30AM  TherapeuticsMD, An Innovative Women's Healthcare Company, And PlushCare, A Virtual Health Platform, Announce Enhanced Access To Women's Health Products PR Newswire
06:30AM  TherapeuticsMD, an Innovative Womens Healthcare Company, and PlushCare, a Virtual Health Platform, Announce Enhanced Access to Womens Health Products Business Wire
Jan-06-20 06:55AM  TherapeuticsMD Announces Participation at the JP Morgan Healthcare Conference Business Wire
Dec-30-19 06:55AM  TherapeuticsMD Announces Amendment to Term Loan Financing Facility with TPG Sixth Street Partners Business Wire
Dec-16-19 02:02PM  Do Hedge Funds Love TherapeuticsMD Inc (TXMD)? Insider Monkey +11.30%
Nov-26-19 07:30AM  Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada TEST Business Wire Releases
07:30AM  Knight and TherapeuticsMD Announce Filing of New Drug Submission for BIJUVA® in Canada Business Wire
Nov-23-19 01:08AM  Edited Transcript of TXMD earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-22-19 08:26AM  Introducing TherapeuticsMD (NASDAQ:TXMD), The Stock That Slid 63% In The Last Three Years Simply Wall St.
Nov-12-19 07:00AM  TherapeuticsMD Announces Participation at the Stifel 2019 Healthcare Conference Business Wire
Nov-06-19 07:05PM  TherapeuticsMD (TXMD) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM  TherapeuticsMD Announces Third Quarter 2019 Financial Results Business Wire
Nov-04-19 10:37AM  Weekly CEO Buys Highlight GuruFocus.com
Nov-01-19 04:05PM  TherapeuticsMD to Report Third Quarter 2019 Results on November 6, 2019 Business Wire +7.52%
Oct-30-19 05:05PM  Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta in Canada Business Wire -7.59%
11:19AM  Did Hedge Funds Drop The Ball On TherapeuticsMD Inc (TXMD) ? Insider Monkey
10:33AM  TherapeuticsMD (TXMD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-29-19 04:05PM  TherapeuticsMD Announces Closing of Its Underwritten Public Offering of Common Stock Business Wire
Oct-24-19 07:46PM  TherapeuticsMD Announces Pricing of Its Underwritten Public Offering of 26 Million Shares of Common Stock Business Wire -22.01%
07:36AM  The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise Benzinga
Oct-23-19 04:45PM  TherapeuticsMD Announces Proposed Underwritten Public Offering of 22 Million Shares of Common Stock Business Wire
04:41PM  TherapeuticsMD Announces Estimated Third Quarter 2019 Financial Results Business Wire
Oct-11-19 07:00AM  TherapeuticsMD Announces Presentations on ANNOVERA at the 2019 Annual Meeting of the American Society for Reproductive Medicine Business Wire
Oct-10-19 06:45AM  TherapeuticsMD Vice President of Business Development Named Finalist in 16th Annual Stevie® Awards for Women in Business Business Wire
Oct-08-19 11:55AM  Edited Transcript of TXMD earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Oct-07-19 08:34AM  3 Biotech Stocks That Could Triple in 2020 TipRanks
Sep-26-19 07:00AM  TherapeuticsMD Announces Participation at the 2019 Cantor Healthcare Conference Business Wire
Sep-24-19 07:00AM  TherapeuticsMD Announces Multiple Presentations Related to IMVEXXY® and BIJUVA® at the 2019 Annual Meeting of the North American Menopause Society Business Wire -5.22%
Sep-18-19 06:30AM  3 Small Biotechs With Favorable Risk Vs. Reward Profiles TheStreet.com
Sep-04-19 10:05AM  Here's Why TherapeuticsMD Jumped 34% in August Motley Fool
Aug-21-19 10:06AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
07:30AM  Analysts Expect Breakeven For TherapeuticsMD, Inc. (NASDAQ:TXMD) Simply Wall St.
Aug-20-19 09:13PM  TherapeuticsMD agrees to pay $200,000 to settle SEC charges American City Business Journals
08:15PM  Therapeuticsmd Inc (TXMD) CEO Robert G Finizio Bought $95,900 of Shares GuruFocus.com
04:53PM  TherapeuticsMD agrees to pay $200,000 to settle SEC charges American City Business Journals
10:46AM  TherapeuticsMD stock slides 6% after SEC charges company with breaking disclosure rules MarketWatch
Aug-12-19 07:15PM  Therapeuticsmd Inc (TXMD) CEO Robert G Finizio Bought $155,119 of Shares GuruFocus.com
Aug-07-19 04:00PM  Here's Why TherapeuticsMD Stock Is Jumping Today Motley Fool +20.86%
Aug-06-19 10:24PM  TherapeuticsMD Inc (TXMD) Q2 2019 Earnings Call Transcript Motley Fool
06:15PM  TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  TherapeuticsMD Announces Second Quarter 2019 Financial Results Business Wire
Jul-25-19 07:00AM  TherapeuticsMD to Report Second Quarter 2019 Results on August 6, 2019 Business Wire
Jul-22-19 10:31AM  Earnings Preview: TherapeuticsMD (TXMD) Q2 Earnings Expected to Decline Zacks
Jul-16-19 08:21AM  Before You Buy TherapeuticsMD, Inc. (NASDAQ:TXMD), Consider Its Volatility Simply Wall St.
Jun-14-19 06:08PM  Edited Transcript of TXMD earnings conference call or presentation 6-May-19 8:30pm GMT Thomson Reuters StreetEvents -5.43%
Jun-12-19 07:25AM  Jim Cramer Shares His Thoughts On TherapeuticsMD, Rite Aid And More Benzinga
Jun-10-19 09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
07:00AM  TherapeuticsMD to Host Investor and Analyst Day Today Business Wire
Jun-07-19 07:15AM  TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA and IMVEXXY® Outside the United States Business Wire
May-29-19 07:00AM  TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City Business Wire
May-08-19 07:00AM  TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference Business Wire
May-07-19 02:06PM  Here's Why TherapeuticsMD Fell as Much as 17.6% Today Motley Fool -16.48%
May-06-19 10:14PM  TherapeuticsMD Inc (TXMD) Q1 2019 Earnings Call Transcript Motley Fool
06:45PM  TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates Zacks
05:33PM  TherapeuticsMD: 1Q Earnings Snapshot Associated Press
04:05PM  TherapeuticsMD Announces First Quarter 2019 Financial Results Business Wire
08:50AM  Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
07:00AM  TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Womens Menopausal Symptoms Affect Men Business Wire
May-03-19 10:38AM  Is TherapeuticsMD Inc (TXMD) A Good Stock To Buy? Insider Monkey
07:00AM  TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA and ANNOVERA at the American College of Obstetricians and Gynecologists 2019 Annual Meeting Business Wire
May-02-19 07:20AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TherapeuticsMD, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Apr-29-19 07:00AM  TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019 Business Wire
Apr-25-19 10:33AM  Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-24-19 04:10PM  TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire
Apr-17-19 07:05AM  TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire
07:00AM  TherapeuticsMD Announces Commercial Availability of BIJUVA in the U.S. Business Wire
Apr-12-19 12:08PM  Is TherapeuticsMD, Inc. (NASDAQ:TXMD) Overpaying Its CEO? Simply Wall St.
Apr-06-19 08:03AM  Here's Why Investors Are Betting Against These 2 Biotech Stocks Motley Fool
Mar-25-19 07:00AM  TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA and ANNOVERA at the Endocrine Society 2019 Annual Meeting Business Wire
Mar-08-19 07:00AM  TherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting Business Wire
Mar-05-19 08:35AM  Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson Fundamental Analysis, Key Performance Indications GlobeNewswire
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krassan MitchellChief Strategy OfficerFeb 03Option Exercise0.20300,00059,387300,000Feb 05 06:07 PM
Krassan MitchellChief Strategy OfficerFeb 03Sale2.26300,000676,9200Feb 05 06:07 PM
Milligan John C.K. IVPresident/SecretaryOct 25Buy2.7572,000198,0001,544,419Oct 29 05:03 PM
Bernick BrianDirectorOct 25Buy2.7536,00099,00098,000Oct 29 04:56 PM
Milligan John C.K. IVPresident/SecretaryOct 25Buy2.7572,000198,0001,544,419Oct 29 05:01 PM
Finizio Robert GCEOOct 25Buy2.7572,000198,00018,325,964Oct 29 04:55 PM
Russell Angus C.DirectorAug 23Buy2.7710,00027,70093,500Aug 26 05:14 PM
Finizio Robert GCEOAug 20Buy2.7435,00095,90018,253,964Aug 20 05:12 PM
Milligan John C.K. IVPresident/SecretaryAug 16Buy2.9310,00029,3003,582,373Aug 19 04:56 PM
Russell Angus C.DirectorAug 15Buy2.9910,00029,90083,500Aug 15 04:33 PM
Russell Angus C.DirectorAug 14Buy2.7625,00069,00073,500Aug 15 04:33 PM
Milligan John C.K. IVPresident/SecretaryAug 12Buy3.1615,00047,4003,572,373Aug 14 04:32 PM
Barlow Jane FDirectorAug 12Buy3.183,1449,9983,144Aug 14 04:33 PM
Thompson Tommy GDirectorAug 09Buy3.045,00015,200690,900Aug 13 04:33 PM
Bernick BrianDirectorAug 09Buy2.8710,00028,70062,000Aug 13 04:31 PM
Finizio Robert GCEOAug 09Buy2.9652,405155,11918,218,964Aug 12 05:32 PM